Immucor in Brief

Immucoris recommended for the treatment of patients with Immunodeficiency disorder.

Preclinical and clinical trials shows, that Immucorhas immunocorrective properties - correction and restoration of the immune status of the organism. Plant natural origin medicine Immucoris absolutely harmless and has a high clinical immunotherapeutic efficacy.

Immucor  now pass registration at the Pharmacological Committee of the Ministry of Health and Social Affairs of Georgia.

 

Immucorhas passed preclinical and clinical trials in following organizations:

  • Medical & Biological Scientific Research Centre  – Company <<Alexis>>;

  • Research Laboratory of Biomedical Technologies, St. Andrew the First-Called Georgian

  • University of the Patriarchate of Georgia;

  • Clinical and Experimental Research Institute of Tbilisi State Medical University;

  • Institute  of  Experimental  Pathology,  Oncology,  and  Radiobiology  at  the  National Academy of  Sciences of Ukraine;

  • Department  of Biochemistry of Ukrainian State University;

  • Bukovin State Medical University of Ukraine;

  • Medical Research Institute of Physical Chemistry at the Ministry of Healthcare of Russian Federation;

  • Pharmacological Department of the Medical University of Russian Federation;

  • Research Institute of the Otsuka Pharmaceutical Co., Japan Tokushima Cell Technology Institute, Japan;

  • Fuji Memorial Institute of the Preclinical Research, Bivako/Japan;

  • Tokushima Otsuka Immunology Research Institute, Japan;

 

Preclinical and  clinical trials shows, that Immucor has immunocorrective properties that make a correction of the immune status of the organism and restore the quantitative and functional indicators T and B of immune cellular systems i.e. T-helper cells, T-cytotoxic cells, T- killers (NK-cells), macrophages and granulocytes. It regulates the correlation of T-helper and T- suppressor cells. It also regulates the indicators of immunoglobulin’s, restore  the production of cytokines, including the tumor necrosis factor (TNF-a) and interferon’s (INF).

Immucor   restores the functional activity of stem haemopoietic cells too, normalizing the

 

content of leukocytes, erythrocytes, neutrophils, thrombocytes, lymphocytes and other blood forming elements. Immucor provides for normalization of the blood biochemical  indicators – total protein, albumin, globulin, urea nitrogen, creatinine, bilirubin,glucose, as well as certain enzymes such as alanine-aminotransferase (ALT), aspartate-aminotransferase (AST), γ- glutamine-transpeptidase (γ-GP) and alkaline phosphatase. The preparation renders a positive influence on the dynamic contents in the bloodstream of carcinoembryonic antigens (CEA), alpha-fetoprotein (AFP), prostate-specific antigen (PSA), as well as the blood contents in mineral compounds of sodium, calcium, potassium.

Immucoris absolutely harmless and has a high clinical immunotherapeutic efficacy for preventive treatment for patients at risk (genetic predisposition coupled with environmental challenges), and those with precancerous lesions; for prophylaxis. It is recommended for persons above 40-50 age, to allow getting rid of senile non-specific diseases, to reduce the risk of cancer, to create the state of the organism in which susceptibility to virus and other infectious diseases are reduced to a minimum Immucoris absolutely harmless and has a high clinical immunotherapeutic efficacy for preventive treatment of the patients at risk (genetic predisposition coupled with environmental challenges), and those with precancerous lesions; For prophylaxis, it is recommended for persons above 40-50 age, to allow getting rid of senile non-specific diseases, to reduce the risk of cancer, to create the state of the organism in which susceptibility to virus and other infectious diseases are reduced to a minimum.

 

Autoimmune Diseases 

Hemorrhagic vasculitis, glomerulonephritis, rheumatism, arthritis and other deformities In autoimmune diseases in 90% of cases are completely stopping autoagression. If the disease is short-term and no rough irreversible changes, visible remission lasts up to 5-6 years.

Medical & Biological Scientific - Research Center“ALEXIS” LTD

© Alexis ltd. 2015. All Rights Reserved. The use of the information on this site is subject to the terms of our Legal Notice. This site is published by Alexis ltd, which is solely responsible for its contents. Product names are trademarks of Alexis ltd. This information is intended for use by our customers, patients, and healthcare professionals. Alexis ltd recognizes that the internet is a global communications medium; however, laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The prescribing information included here may not be appropriate for use outside Georgia.